课题基金 / 基金详情

Studies on the behavior of hantavirus envelope glycoprotein in adsorption and invasion to target cells.

Studies on the behavior of hantavirus envelope glycoprotein in adsorption and invasion to target cells.
汉坦病毒包膜糖蛋白对靶细胞吸附和侵袭行为的研究。
批准号:
17590410
负责人:
MORIMATSU Kumiko
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

MORIMATSU Kumiko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Hantaviruses are causative agents for rodent-borne viral zoonosis, HFRS and HPS. Envelope glycoproteins G1 and G2 induce neutralizing antibodies. Monoclonal antibodies possessing neutralizing activities showed fusion inhibition activities. This means vaccine target epitope for hantavirus is a fusion responsible region in envelope protein. I studied the role of envelope glycoproteins in establishment of infection in cells. At the first, we found highly sensitive cell lines (A549, BHK and VeroE6 cells) and non-permissive cell lines (MDBK) by using pseudotype VSV screening. AlphaVbeta3 integrin was reported as candidate of the cellular receptor for hantavirus entry. Therefore, we tried to induce alphaVbeta3 into MDBK. I could not detect change of infectivity in that cells. However, transfection efficiency of plasmid constract to MDBK cells were not enough to evaluate the effect of molecules. Otherwise, anti-beta3 integrin antibodies were not inhibit cellular entry of hantavirus in permissive cells found in this study. So that this molecules was considered not to be major receptor molecules in these cells. Next, I screened bindings of glycolipids from permissive cell line Vero E6 cells against hantavirus glycoprotein. Any significant binding was not detected between glycolipids and envelope proteins. These results suggested that the cellular receptor of hantavirus must be protein molecules except alphaVbeta3 integrin. Finally, a clone 5 of MDBK cells was established as relative high DNA induction and non-permissive line. And cDNA libraly from permissive cell line A5449 was produced. This study established the basis for analysis of interaction between hantavirus envelope glycoproteins and cellular molecules.
期刊论文(17)
专著(0)
科研奖励(0)
会议论文
Arikawa J Development of serological assays for Thottapalayam virus, an insectivore-borne Hantavirus.
Arikawa J 开发了 Thottapalayam 病毒(一种食虫传播的汉坦病毒)的血清学检测方法。
DOI: --
发表时间: 2007
期刊: Clin Vaccine Immunol 14
影响因子: --
作者: [Okumura M, Yoshimatsu K, Kumperasart S, Nakamura I, Ogino M, Taruishi M, Sungdee A, Pattamadilok S, Ibrahim IN, Erlina S, Agui T, Yanagihara R]
通讯作者: Yanagihara R
DOI: 10.1128/cvi.00347-06
发表时间: 2007-02-01
期刊: CLINICAL AND VACCINE IMMUNOLOGY
影响因子: --
作者: [Okumura, Megumi, Yoshimatsu, Kumiko, Arikawa, Jiro]
通讯作者: Arikawa, Jiro
DOI: 10.4269/ajtmh.2006.75.994
发表时间: 2006-11-01
期刊: AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
影响因子: 3.3
作者: [Pattamadilok, Sirima, Lee, Byoung-Hee, Arikawa, Jiro]
通讯作者: Arikawa, Jiro
A pilot study for serological evidence of hantavirus infection in human population in south India
印度南部人群汉坦病毒感染血清学证据的初步研究
DOI: --
发表时间: 2005
期刊: Indian J. Med. Res. 122
影响因子: --
作者: [Chandy, S., et. al.]
通讯作者: et. al.
8
    Studies on fever with unknown origin (FUO0 in South and South East Asia
    • 批准号:
      23590770
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.41万
    • 财政年份:
      2011
    • 负责人:
      MORIMATSU Kumiko
    • 依托单位:
    Development of hantavirus vaccine and rapid diagnosis kit by using soluble recombinant envelope glycoproteins
    • 批准号:
      13556046
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.02万
    • 财政年份:
      2001
    • 负责人:
      MORIMATSU Kumiko
    • 依托单位:
    海外基金